openPR Logo
Press release

Duchenne Muscular Dystrophy Treatment Market to Reach US$ 636.22 Million by 2030, Growing at a CAGR of 11.2%

04-14-2023 08:50 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: PROPHECY MARKET INSIGHTS

Duchenne Muscular Dystrophy Treatment Market

Duchenne Muscular Dystrophy Treatment Market

Duchenne muscular dystrophy (DMD) is a rare genetic disorder that affects primarily boys and is characterized by progressive muscle degeneration and weakness. There is currently no cure for DMD, and treatment is focused on managing symptoms and improving quality of life.
The Duchenne muscular dystrophy treatment market includes a range of therapies aimed at slowing the progression of the disease, improving muscle function, and managing symptoms. These therapies include medications, physical therapy, and supportive care measures such as respiratory support.One of the most common treatments for DMD is the use of corticosteroids, which can help improve muscle strength and delay disease progression. Other medications, such as exon-skipping drugs and gene therapy, are also being developed to target the underlying genetic cause of DMD.

Ask Report of Duchenne Muscular Dystrophy Treatment Market:
https://www.prophecymarketinsights.com/market_insight/Global-Duchenne-Muscular-Dystrophy-Treatment-3969

Possibilities for Growth Duchenne Muscular Dystrophy Treatment Market:

There are several possibilities for growth in the Duchenne muscular dystrophy treatment market:
1.Development of new therapies: There is significant ongoing research and development focused on developing new therapies for DMD.
2.Expansion into new markets: While the majority of DMD patients are currently based in developed countries, there is significant potential for growth in emerging markets as access to healthcare improves. Pharmaceutical and biotech companies may seek to expand into these markets and offer their products to patients who would otherwise not have access to them.
3.Increased use of combination therapies: While corticosteroids remain the most commonly used therapy for DMD, there is growing interest in the use of combination therapies that target multiple aspects of the disease.
4.Improved delivery mechanisms: Many DMD therapies are administered via intravenous infusion or injection, which can be inconvenient and uncomfortable for patients.
5.Greater emphasis on patient-centered care: As the focus of healthcare shifts towards patient-centered care, there is likely to be increased demand for treatments that improve quality of life for patients with DMD.

Regional Analysis:
• North America
o U.S.
o Canada

• Europe
o UK
o Germany
o Spain
o France
o Italy
o Russia
o Rest of Europe

• Asia Pacific
o Japan
o India
o China
o South Korea
o Australia
o Rest of Asia-Pacific

• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America

• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Rest of Middle East & Africa

Get your Customized Research Report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/3969

List of Top Key Players in Duchenne Muscular Dystrophy Treatment Market:
• Bristol-Myers Squibb Company
• Fibrogen Inc.
• Eli Lilly and Company
• Nobelpharma Co. Ltd
• NS Pharma Inc.
• Pfizer Inc.
• PTC Therapeutics
• Santhera Pharmaceuticals
• Sarepta Therapeutics

Reasons To Purchase A Market Report On Duchenne Muscular Dystrophy Treatment Market:
•An in-depth overview of the market dynamics, including market size, trends, drivers, and challenges, can be found in a research study, which may aid organisations in making strategic choices.
•A research report may give organisations information about their rivals' plans, as well as their advantages and disadvantages in the market. This information can be used to improve corporate strategy.
•By offering information on the market potential, expansion prospects, and industry hazards, a research study may assist investors in making wise investment selections.
•By offering insights into client preferences, requirements, and desires, a research study may assist firms in creating better goods that more effectively cater to their target market.
•By offering insights into consumer behaviour, tastes, and trends, a research report may assist firms in creating better marketing strategies. This enables them to create more specialised and successful marketing campaigns.
•A research study may assist companies in keeping abreast of the most recent regulatory standards and regulations, ensuring compliance and preventing fines or other consequences.

Other related Reports:
fNIRS Brain Imaging System Market:
https://www.prophecymarketinsights.com/market_insight/Global-fNIRS-Brain-Imaging-System-Market-4656

Precision Medical Imaging Market:
https://www.prophecymarketinsights.com/market_insight/Global-Precision-Medical-Imaging-Market-4375

Rheumatoid Arthritis Therapeutics Market:
https://www.prophecymarketinsights.com/market_insight/Global-Rheumatoid-Arthritis-Therapeutics-Market-4349

To know more
Contact Us:
Sales
Prophecy Market Insights
📞+1 860 531 2574
✉ Email- sales@prophecymarketinsights.com
🌐 Website- www.prophecymarketinsights.com

About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Duchenne Muscular Dystrophy Treatment Market to Reach US$ 636.22 Million by 2030, Growing at a CAGR of 11.2% here

News-ID: 3013184 • Views:

More Releases from PROPHECY MARKET INSIGHTS

Power Purchase Agreement (PPA) Market Poised for Strong Growth Amid Rising Renewable Energy Adoption
Power Purchase Agreement (PPA) Market Poised for Strong Growth Amid Rising Renew …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights Introduction The Power Purchase Agreement (PPA) Market is experiencing remarkable momentum, driven by the global transition toward renewable energy, carbon reduction targets, and rising demand for cost-effective electricity procurement models. PPAs-long-term contracts between electricity producers and buyers-are becoming a critical mechanism for corporations, utilities, and governments to achieve energy security, price stability, and sustainability commitments. With the accelerating deployment of solar, wind, and
Nutraceutical Packaging Market to Witness Robust Growth Amid Rising Health and Wellness Trends
Nutraceutical Packaging Market to Witness Robust Growth Amid Rising Health and W …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights Introduction The Nutraceutical Packaging Market is witnessing significant growth, fueled by rising consumer awareness around health, nutrition, and preventive healthcare. Nutraceuticals-ranging from dietary supplements and functional foods to vitamins, minerals, and herbal products-require specialized packaging that ensures shelf life, product integrity, safety, and consumer appeal. With increasing demand for convenient, eco-friendly, and innovative packaging solutions, companies are investing in advanced materials, smart labeling,
Japan Regulatory Affairs Outsourcing Market Set to Reach USD 0.4 Billion by 2035 at 7.71% CAGR
Japan Regulatory Affairs Outsourcing Market Set to Reach USD 0.4 Billion by 2035 …
Pune, India - September 5, 2025 - The Japan Regulatory Affairs Outsourcing Market is witnessing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on external partners for regulatory compliance. By 2035, the market is projected to reach USD 0.4 billion, rising from USD 0.3 billion in 2025, expanding at a CAGR of 7.71% during the forecast period. Get a Sample Copy of Report :- https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5849 This growing demand underscores
Europe Regulatory Affairs Outsourcing Market to Reach USD 4.2 Billion by 2035, Driven by Rising Demand for Compliance Expertise
Europe Regulatory Affairs Outsourcing Market to Reach USD 4.2 Billion by 2035, D …
Pune, India - September 2, 2025 - The Europe Regulatory Affairs Outsourcing Market is experiencing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on specialized partners for regulatory compliance. According to recent analysis, the market size was valued at USD 2.0 billion in 2025 and is projected to expand to USD 4.2 billion by 2035, registering a CAGR of 7.70% during the forecast period. Get Sample Copy of

All 4 Releases


More Releases for Duchenne

Emerging Trends Influencing The Growth Of The Duchenne Muscular Dystrophy (DMD) …
The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Expected to Be by 2034? In recent times, the market size for Duchenne Muscular Dystrophy (DMD) therapeutics has seen a significant
Rising Prevalence Of Chronic Diseases Fuels Growth In The Duchenne Muscular Dyst …
What industry-specific factors are fueling the growth of the duchenne muscular dystrophy market? The rise in chronic diseases is projected to stimulate the expansion of the Duchenne muscular dystrophy market in the coming years. Chronic diseases are health complications that endure for a minimum of a year. Duchenne muscular dystrophy is instrumental in the increase of chronic diseases as it addresses the unique therapeutic requirements of those suffering from this genetic
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be? The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives. The Duchenne muscular dystrophy (DMD) therapeutics
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market